Rescheduling psilocybin and MDMA in Australia - A process explainer There is a proposal before Australia's poisons, medicines and drug regulator, the TGA (Therapeutic Goods Administration) to down-schedule MDMA and psilocybin from Schedule 9 to Schedule 8, for use in limited therapeutic settings
For now, it is advisable for individuals taking GLP-1 medications, such as semaglutide or tirzepatide, to discuss any new or unusual symptoms with a healthcare professional.
Some patients prefer in-office administration, while others feel comfortable doing their weekly injections at home after we show them how
17(12): CR677CR682.
2018, doi: 10.1007/s00296-018-4142-x Chourpiliadis, C., et al, "Use of Common Psychiatric Medications and Risk and Prognosis of Amyotrophic Lateral Sclerosis," JAMA Network Open, June 4, 2024, doi:10.1001/jamanetworkopen.2025.14437 Meron, M.K., et al, "GLP-1 receptor agonists and the risk of fragility fractures in older adults with type 2 diabetes," Journal of Clinical Endocrinology & Metabolism, Feb.10, 2026, doi: 10.1210/clinem/dgag056 Luo, Y., et al, "GLP-1 receptor agonists in eye disease: a comprehensive review of current research and future potential," BMC Ophthalmology, Jan